Earnings History Data for Edgewise Therapeutics, Inc. (EWTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Edgewise Therapeutics, Inc.
Edgewise Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing orally bioavailable, small molecule therapies for rare muscle disorders. Edgewise Therapeutics Inc. is based in Boulder, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 03-11-2022 | PM | 8:00 AM ET (Nov 3) |
EWTX | Edgewise Therapeutics | 470.00 | -0.34 | -0.36 | 0.00 | Edgewise Therapeutics GAAP EPS of -$0.34 beats by $0.02 [11/3/2022 9:29 AM] |
10.10 | 0.70 (7.45%) |
9.40 | 0.0 (0.00%) |
5.41 - 22.98 | 73,942 | 190,000 | 11,850 | |
| 04-08-2022 | PM | EWTX | Edgewise Therapeutics | 435.00 | -0.32 | -0.34 | 0.00 | Edgewise Therapeutics GAAP EPS of -$0.32 beats by $0.02 [8/4/2022 9:13 AM] |
10.14 | 0.94 (10.22%) |
9.20 | 0.0 (0.00%) |
5.41 - 22.98 | 158,609 | 210,000 | 6,544 | ||
| 11-05-2022 | PM | EWTX | Edgewise Therapeutics | 369.00 | -0.30 | -0.29 | 0.00 | Edgewise Therapeutics GAAP EPS of -$0.30 misses by $0.02 [5/11/2022 8:51 AM] |
7.04 | -0.31 (-4.22%) |
7.35 | 0.0 (0.00%) |
6.95 - 29.98 | 198,230 | 150,000 | 1,086 | ||
| 24-02-2022 | PM | EWTX | Edgewise Therapeutics, Inc. | 573.31 | -0.26 | -0.28 | 0.00 | Edgewise Therapeutics GAAP EPS of -$0.26 beats by $0.02 [2/24/2022 8:26 AM] |
11.35 | -0.15 (-1.30%) |
11.50 | 0.0 (0.00%) |
0.0 - 0.0 | 64,191 | 0 | 338 | ||
| 10-11-2021 | PM | EWTX | Edgewise Therapeutics | 989.00 | -0.26 | -0.22 | 0.00 | Edgewise Therapeutics EPS misses by $0.04 [11/10/2021 9:28 AM] |
19.74 | -0.58 (-2.85%) |
20.32 | 0.0 (0.00%) |
13.60 - 40.49 | 74,494 | 150,000 | 298 | ||
| 09-08-2021 | PM | EWTX | Edgewise Therapeutics, Inc. | 889.00 | -0.21 | -0.18 | 0.00 | Edgewise Therapeutics EPS misses by $0.03 [8/9/2021 9:18 AM] |
18.26 | 0.07 (0.38%) |
0.0 | 0.0 (0.00%) |
16.87 - 40.49 | 12,200 | 60,000 | 0 | ||